The commercially available STAT3 inhibitor 5,15-diphenylporphyrin (5,15-DPP) does not directly interact with STAT3 core residues 127–722
暂无分享,去创建一个
[1] D. Backos,et al. Strategies and Approaches of Targeting STAT3 for Cancer Treatment. , 2016, ACS chemical biology.
[2] Guocheng Yuan,et al. Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity , 2015, Molecular and Cellular Biology.
[3] F. Baran-Marszak,et al. STAT3 inhibitors for cancer therapy , 2013, JAK-STAT.
[4] G. Blatch,et al. STAT3 interacts directly with Hsp90 , 2012, IUBMB life.
[5] Adam B Castoreno,et al. Small molecule probes of cellular pathways and networks. , 2011, ACS chemical biology.
[6] K. Matsuno,et al. Novel high-throughput screening system for identifying STAT3-SH2 antagonists. , 2009, Biochemical and biophysical research communications.
[7] P. Yue,et al. Targeting STAT3 in cancer: how successful are we? , 2009, Expert opinion on investigational drugs.
[8] W. Guida,et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.
[9] R. Aebersold,et al. Expression of a tyrosine phosphorylated, DNA binding Stat3β dimer in bacteria , 1998, FEBS letters.
[10] S. Becker,et al. Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.
[11] R. Simpson,et al. STAT3 forms stable homodimers in the presence of divalent cations prior to activation. , 1998, Biochemical and biophysical research communications.
[12] F. Baran-Marszak,et al. STAT 3 inhibitors for cancer therapy Have all roads been explored ? , 2012 .
[13] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..